-
公开(公告)号:US20100203113A1
公开(公告)日:2010-08-12
申请号:US12600996
申请日:2008-05-15
IPC分类号: A61K9/127 , C07D487/04 , A61K31/55 , C12N5/071 , A61P35/00
CPC分类号: C07D487/04
摘要: The invention provides dBHD-based compositions and dBHD analog compositions, and pharmaceutical compositions comprising them, e.g., in the form of liposomes and nanoparticles comprising them, and methods of making and using them. In one embodiment, these dBHD analogs are used to inhibit a dysfunctional stem cell and/or a cancer (tumor) stem cell.
摘要翻译: 本发明提供了基于dBHD的组合物和dBHD类似物组合物,以及包含它们的药物组合物,例如以脂质体和包含它们的纳米颗粒的形式,以及制备和使用它们的方法。 在一个实施方案中,这些dBHD类似物用于抑制功能障碍的干细胞和/或癌(肿瘤)干细胞。
-
公开(公告)号:US4385130A
公开(公告)日:1983-05-24
申请号:US216676
申请日:1980-12-15
IPC分类号: B01J39/20 , C08F259/08 , C08J5/22
CPC分类号: C08J5/225 , B01J39/20 , C08F259/08 , C08J5/2243 , H01M2/1653 , H01M8/1023 , H01M8/1039 , H01M8/1072 , C08J2325/04 , Y02P70/56
摘要: A cation exchange resin, suitable for use as a membrane in electrolysis cells, comprising a perhalogenated fluorine containing hydrocarbon polymeric substrate with pendant active side chains containing dicarboxylic acid groups or their derivatives, and method of preparation thereof.
摘要翻译: 适合用作电解槽中的膜的阳离子交换树脂及其制备方法,该阳离子交换树脂包括具有含有二羧酸基团的侧链活性侧链的全卤代含氟烃聚合物基质及其衍生物。
-
3.
公开(公告)号:US08957097B2
公开(公告)日:2015-02-17
申请号:US13386783
申请日:2010-07-23
申请人: Amos B. Smith, III , Zhuqing Liu , Anne-Marie L. Hogan , Doralyn S. Dalisay , Tadeusz F. Molinski
发明人: Amos B. Smith, III , Zhuqing Liu , Anne-Marie L. Hogan , Doralyn S. Dalisay , Tadeusz F. Molinski
IPC分类号: A01N43/76 , A61K31/42 , C07D487/00 , C07D513/00 , C07D309/00 , A01N43/90 , C07D498/22
CPC分类号: A01N43/90 , C07D498/22
摘要: The present invention is directed to hemi phorboxazole A: and its stereoisomers, as well as derivatives of hemi phorboxazole A of formula I: wherein ring A is aryl or a 5- or 6-membered heteroaryl optionally substituted with one or more of halogen, —OH, or —C1-6alkyl; and R is —CN, a 5- or 6-membered heteroaryl, or halogen; and the pharmaceutically acceptable salt forms thereof, in addition to methods of using these compounds.
摘要翻译: 本发明涉及半柔霉唑A及其立体异构体,以及式I的半菲唑唑A的衍生物:其中环A为芳基或任选被一个或多个卤素取代的5-或6-元杂芳基, OH或-C 1-6烷基; 和R为-CN,5-或6-元杂芳基或卤素; 和其药学上可接受的盐形式,以及使用这些化合物的方法。
-
4.
公开(公告)号:US20130030027A1
公开(公告)日:2013-01-31
申请号:US13386783
申请日:2010-07-23
申请人: Amos B. Smith, III , Zhuqing Liu , Anne-Marie L. Hogan , Doralyn S. Dalisay , Tadeusz F. Molinski
发明人: Amos B. Smith, III , Zhuqing Liu , Anne-Marie L. Hogan , Doralyn S. Dalisay , Tadeusz F. Molinski
IPC分类号: A61K31/424 , C07D493/22 , A61K31/357 , A61P35/00 , A61K31/427 , C07D513/22 , A61K31/422 , A61P31/10 , C07D498/22 , A61K31/381
CPC分类号: A01N43/90 , C07D498/22
摘要: The present invention is directed to hemi phorboxazole A: and its stereoisomers, as well as derivatives of hemi phorboxazole A of formula I: wherein ring A is aryl or a 5- or 6-membered heteroaryl optionally substituted with one or more of halogen, —OH, or —C1-6alkyl; and R is —CN, a 5- or 6-membered heteroaryl, or halogen; and the pharmaceutically acceptable salt forms thereof, in addition to methods of using these compounds.
摘要翻译: 本发明涉及半柔霉唑A及其立体异构体,以及式I的半菲唑唑A的衍生物:其中环A为芳基或任选被一个或多个卤素取代的5-或6-元杂芳基, OH或-C 1-6烷基; 和R为-CN,5-或6-元杂芳基或卤素; 和其药学上可接受的盐形式,以及使用这些化合物的方法。
-
5.
公开(公告)号:US08304408B2
公开(公告)日:2012-11-06
申请号:US12600996
申请日:2008-05-15
CPC分类号: C07D487/04
摘要: The invention provides dBHD-based compositions and dBHD analog compositions, and pharmaceutical compositions comprising them, e.g., in the form of liposomes and nanoparticles comprising them, and methods of making and using them. In one embodiment, these dBHD analogs are used to inhibit a dysfunctional stem cell and/or a cancer (tumor) stem cell.
摘要翻译: 本发明提供了基于dBHD的组合物和dBHD类似物组合物,以及包含它们的药物组合物,例如以脂质体和包含它们的纳米颗粒的形式,以及制备和使用它们的方法。 在一个实施方案中,这些dBHD类似物用于抑制功能障碍的干细胞和/或癌(肿瘤)干细胞。
-
-
-
-